News
Having gastroesophageal reflux disease is associated with an increased risk for colonic neoplasia, including colon polyps and ...
Dr Ray O’Connor takes a look at the latest clinical articles on Gastro Oesophageal Reflux Disease, and its diagnosis and ...
One specific kind of acid reflux, laryngopharyngeal reflux, can cause lesser-known symptoms like coughing, hoarseness, and a ...
1d
Sportschosun on MSNGLP1 receptor agonists, SGLT2 inhibitors risk gastroesophageal reflux disease and complications ↑Recently, as the prescription of GLP-1 receptor agonists, which is in the spotlight as a treatment for obesity, side effects ...
4d
India Today on MSNActor Aasif Khan clarifies health scare was reflux disease, not heart attackAasif Khan, known for his role in Panchayat, addresses rumours about his recent health scare, confirming it was not a heart ...
“Some women in midlife experience these symptoms more intensely, potentially due to increased visceral sensitivity, changes ...
For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased risk for gastroesophageal reflux disease (GERD) and its complications compared ...
Actor Aasif Khan, admitted to the hospital earlier this week, has clarified that he did not suffer from a heart attack as reported but had gastroesophageal reflux disease, or heartburn. Read on to ...
4d
Onlymyhealth on MSNAsif Khan Clarifies, He Did Not Suffer A Heart Attack, But Was Gastrointestinal Reflux, How to Identify GERD from Heart AttackIn a video message that became immediately viral Khan explained that he had not suffered a cardiac event but was instead ...
5don MSN
Aasif Khan has been discharged from the hospital after experiencing symptoms of gastroesophageal reflux disease, which felt ...
The Rheumatoid Arthritis Market value was US$ $$ billion in 2022. The Rheumatoid Arthritis Market value is forecast to reach US$ $$ billion by 2032, growing at a compound annual growth rate (CAGR) $% ...
The Peptide Therapeutics Market value was US$ $$ billion in 2022. The Peptide Therapeutics Market value is forecast to reach US$ $$ billion by 2032, growing at a compound annual growth rate (CAGR) $% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results